AnaSpec
Private Company
Funding information not available
Overview
AnaSpec is a well-established, privately-held biotech CMO with over 30 years of experience in peptide synthesis and proteomic solutions. Its core business model combines service-based custom manufacturing with a catalog of research products, serving academia, diagnostics, and biopharma. The company has strategically expanded into GMP manufacturing for advanced applications like diagnostics, cell therapy, and neo-antigen development, positioning itself in high-growth niche markets. With ISO 7 certified cleanrooms and a focus on quality, AnaSpec is a key enabler for research and therapeutic development.
Technology Platform
Advanced peptide synthesis (including cyclic peptides), GMP peptide manufacturing, and bioconjugation (e.g., fluorescent dyes) for research, diagnostic, and therapeutic applications.
Opportunities
Risk Factors
Competitive Landscape
AnaSpec competes in a fragmented market with other specialized peptide CMOs (e.g., Bachem, PolyPeptide, CPC Scientific) and large, diversified CDMOs (e.g., Lonza, Thermo Fisher Scientific) that offer peptide services. Its differentiation lies in its deep expertise in complex and modified peptides, fluorescent dye conjugation, and a focused vertical integration from research to GMP. It also competes with catalog reagent suppliers for its research products.